Changes in neuropsychological tests and brain metabolism after bariatric surgery

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 11, 2014, Pages E2347-E2352

  Marques, Emerson Leonildo ^a   Halpern, Alfredo ^a   Mancini, Marcio Corrêa ^a   De Melo, Maria Edna ^a   Horie, Nídia Celeste ^a   Buchpiguel, Carlos Alberto ^a   Coutinho, Artur Martins Novaes ^a   Ono, Carla Rachel ^a   Prando, Silvana ^a   Santo, Marco Aurélio ^a   Cunha Neto, Edécio ^a   Fuentes, Daniel ^a   Cercato, Cintia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; BRAIN FUNCTION; BRAIN METABOLISM; BRAZIL; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; EXECUTIVE FUNCTION; FEMALE; HUMAN; INFLAMMATION; METABOLIC PARAMETERS; NEUROPSYCHOLOGICAL TEST; OBESITY; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; UNIVERSITY; WEIGHT REDUCTION; BRAIN; MEMORY; METABOLISM; MIDDLE AGED; OBESITY, MORBID; PSYCHOLOGY; TREATMENT OUTCOME;

ADULT; BARIATRIC SURGERY; BRAIN; COGNITION; EXECUTIVE FUNCTION; FEMALE; HUMANS; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OBESITY, MORBID; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84909996338     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2068     Document Type: Article

References (20)

1. Cournot M, Marquie JC, Ansiau D, et al. Relation between body mass index and cognitive function in healthy middle-aged men and women. In: Neurology. 2006; 67 (7): 1208-1214.
2. Anstey KJ, Cherbuin N, Budge M, Young J. Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev. 2011; 12: e426-e437.
3. Waxman AD, Herholz K, Lewis DH, et al. Society of Nuclear Medicine Procedure Guideline for FDG PET Brain Imaging. In. USA: Society of NuclearMedicineandMolecularImaging.1st ed. Society of NuclearMedicine; 2009, https: //www.snmmi.org/ClinicalPractice/content.aspx?Item Number-6414.
4. Buckner RL, Andrews-Hanna JR, Schacter DL. The brain's default network: anatomy, function, and relevance to disease.AnnNYAcad Sci. 2008; 1124: 1-38.
5. DennisNA, Browndyke JN, Stokes J, et al. Temporal lobe functional activity and connectivity in young adult APOE varε4 carriers. Alzheimers Dement. 2010; 6: 303-311.
6. Clark I, Atwood C, Bowen R, Paz-Filho G, Vissel B. Tumor necrosis factor-induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales. Pharmacol Rev. 2012; 64: 1004-1026.
7. Kulstad JJ, Green PS, Cook DG, et al. Differential modulation of plasma β-amyloid by insulin in patients with Alzheimer disease. Neurology. 2006; 66 (10): 1506-1510.
8. Frank S, Wilms B, Veit R, et al. Altered brain activity in severely obese women may recover after Roux-en Y gastric bypass surgery. Int J Obes (Lond). 2014; 38 (3): 341-34.8
9. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol. 1997; 42: 85-94.
10. Wang J, Zuo X, Dai Z, et al. Disrupted functional brain connectome in individuals at risk for Alzheimer's disease. Biol Psychiatry. 2013; 73: 472-481.
11. Robertson IH. A right hemisphere role in cognitive reserve. Neurobiol Aging. 2014; 35: 1375-1385.
12. de Haan W, Mott K, van Straaten EC, Scheltens P, Stam CJ. Activity dependent degeneration explains hub vulnerability in Alzheimer's disease. PLoS Comput Biol 2012; 8: e1002582.
13. Bakker A, Krauss GL, Albert MS, et al. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron. 2012; 74: 467-474.
14. Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment. 4th ed. New York: Oxford University Press; 2004.
15. Yaffe K. Metabolic syndrome and cognitive disorders: is the sum greater than its parts? Alzheimer Dis Assoc Disord. 2007; 21: 167-171.
16. Craft S, Baker LD, Montine TJ, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 2012; 69: 29-38.
17. Dandona P, Mohamed I, Ghanim H, et al. Insulin suppresses the expression of amyloid precursor protein, presenilins, and glycogen synthase kinase-3β in peripheral blood mononuclear cells. J Clin Endocrinol Metab. 2011; 96: 1783-1788.
18. Monte SV, Caruana JA, Ghanim H, et al. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. Surgery. 2012; 151: 587-593.
19. Long-Smith CM, Manning S, McClean PL, et al. The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-β plaque and glial pathology in a mouse model of Alzheimer's disease. Neuromolecular Med. 2013; 15: 102-114.
20. Chaudhuri A, Ghanim H, Vora M, et al. Exenatide exerts a potent antiinflammatory effect. J Clin Endocrinol Metab. 2012; 97: 198-207.